|
心肌梗塞再灌注中血浆白细胞介素6的动态变化和其单克隆抗体的保护效应 |
|
丁文惠 吴付轩 李大元 张钧华 王建中 唐朝枢 朱国英 汪丽蕙
【摘要】 目的 探讨急性心肌梗塞(AMI)心肌缺血再灌注过程中血浆白细胞介素6(IL-6)的动态变化及其意义和其单克隆抗体的保护作用。方法 (1)用ELISA方法和FACSORT流式细胞仪测定28例经链激酶(SK)或重组组织型纤溶酶原激活剂(t-PA)溶栓治疗的AMI患者入院即刻,再灌注1、4.5、10、20小时血浆IL-6水平和中性粒细胞表面粘附分子(CD11b)蛋白表达。(2)在兔的缺血再灌注模型上检测IL-6和CD11b,以及缺血心肌组织白细胞聚积和髓过氧化酶(MPO)活性。结果 (1)28例AMI患者中,13例溶栓治疗后血管再通(A组),15例未通(B组)。两组溶栓治疗前IL-6和CD11b表达差异无显著性,但明显高于正常对照组(P<0.01),A组在血管再通后1小时、4.5小时显著高于B组。(2)在兔缺血再灌注模型上,血浆IL-6和CD11b的表达和AMI患者相似。在缺血心肌组织中,中性粒细胞和MPO的活性明显升高。IL-6释放与CD11b表达及MPO活性相关(r=0.924, 0.622, P<0.01)。缺血1.5小时后再灌注4小时比单纯心肌缺血1.5小时梗塞面积扩大[(43.8±3.9) % vs (38.7±3.5) %, P<0.05],但比心肌缺血5.5小时梗塞面积缩小[(43.8±3.9) % vs (52.9±4.8) %, P<0.05]。IL-6单克隆抗体明显减少CD11b表达、MPO活性及梗塞面积[(27.5±3) % vs (43.8±3.9) %, P<0.01]。结论 IL-6在心肌缺血再灌注后的炎症损伤中起关键作用,监测血浆IL-6和CD11b的动态变化将有助于临床对心肌缺血再灌注损伤的认识。IL-6单克隆抗体对心肌缺血再灌注后的炎症损伤将有潜在的临床治疗价值。 【关键词】 白细胞介素6 单克隆抗体 心肌梗塞 再灌注损伤
The change of plasma interleukin-6 level and cardiac protective effect of monoclonal antibody to IL-6 during myocardial infarction reperfusion DING Wenhui, WU Fuxuan, LI Dayuan, et al. Cardiovascular Department, First Hospital, Beijing Medical University, Beijing 100034 【Abstract】 Objective In order to study the change and role of plasma interleukin-6 (IL-6) and the effect of its monoclonal antibody (McAb-IL6) during myocardial infarction reperfusion in acute myocardial infarction (AMI). Methods (1) In 28 patients with AMI who received SK or rt-PA thrombolysis plasma IL-6 by ELISA and CD11b expression of neutrophil by flowcytometry were measured at admission and 1,4.5, 10, 20 hours after therapy. (2) In the rabbit model with ischemia reperfusion, similar measurements were performed as well as the accumulation of neutrophils and myeloperoxidase (MPO) activity in ischemic cardiac tissue. Results (1) Among 28 patients, 13 of them developed reperfusion (Group A) and 15 did not (Group B). Plasma IL-6 level and CD11b expression at admissi[1] [2] [3] 下一页 上一个医学论文: 经皮冠状动脉腔内成形术前后血小板功能及前列腺素水平的变化及其临床意义 下一个医学论文: 11省市队列人群心血管病发病前瞻性研究I 危险因素水平与心血管病发病的关系
|
|
|
|
|
|
|